43.32 +0.14 (0.33%)
After hours: 4:18PM EDT
|Bid||43.00 x 800|
|Ask||46.00 x 800|
|Day's Range||43.00 - 45.18|
|52 Week Range||40.56 - 63.04|
|Beta (3Y Monthly)||-0.05|
|PE Ratio (TTM)||11.65|
|Earnings Date||Nov 1, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||51.50|
MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, November 1, 2018 at 10:00 a.m. ET, to discuss results from operations for the quarter and the nine months ended September 30, 2018. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner based in Sunrise, Fla. comprised of the nation's leading providers of physician services.
NEW YORK, Oct. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
MEDNAX, Inc. (MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology, and management services, will exhibit at the ANESTHESIOLOGY® 2018 annual meeting presented by the American Society of Anesthesiologists (ASA) from Oct. 13-15 at the Moscone Center in San Francisco. Clinical leadership and recruiters from American Anesthesiology, a MEDNAX company, will be on-site at Booth #1310.
MEDNAX, Inc. , today announced the acquisition of South Dade Neonatology, a private neonatology practice based in Miami.
Nationally known cardiothoracic anesthesiologist and healthcare executive to join Surgical Directions’ industry-leading physician consulting team
MEDNAX, Inc. (MD), today announced the acquisition of Radiology Specialists, LTD, a private radiology physician group based in Las Vegas. This marks the Company’s seventh radiology services practice acquisition and first in the state of Nevada, further establishing MEDNAX Radiology Solutions as a recognized leader in radiology, an innovator in health care informatics and a pioneer in telemedicine. Comprising 25 board certified and fellowship trained physicians, the practice provides a broad range of diagnostic and interventional radiology services, including body imaging, neuroradiology, musculoskeletal imaging, cardiac imaging, breast imaging, pediatric radiology, nuclear medicine and image guided therapy.
Let's see if MEDNAX, Inc. (MD) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Mednax Inc (NYSE: MD ) shares came under pressure Friday, dipping about 4 percent after Paul Singer's Elliott Associates declared a reduction in stake held in the company. The Analyst Leerink analyst Ana ...
Paul Singer’s Elliott Associates built a reputation as one of the fiercest activist hedge funds in the investment world. You can easily find an article about this fund by a major media company every week. Paul Singer doesn’t have any problem raising capital whenever he wants to. Yet, we aren’t impressed by its performance at all. […]
DaVita (DVA) reported revenues of ~$2.9 billion in the second quarter of 2018, which is a 6.9% YoY (year-over-year) growth compared to $2.7 billion in the second quarter of 2017. DaVita reported 6.9% growth in its top line to $2.89 billion, including an 11.1% growth in revenues from US dialysis and related lab services to $2.57 billion, offset by a 17.7% decrease in revenues for other ancillary services and strategic initiatives in the second quarter of 2018. Medicare and Medicare Advantage revenues were $1.5 billion in the second quarter of 2018, a 16.2% growth compared to $1.3 billion in the second quarter of 2017.
DaVita (DVA) is a biotechnology company focused on the discovery, development, and commercialization of specialist medicines to cater to the medical needs in rare diseases and other specialized conditions. DaVita reported non-GAAP EPS of $1.15 on revenues of $2.9 billion, a 6.9% growth YoY (year-over-year) compared to $2.7 billion in the second quarter of 2017.
NEW YORK , Sept. 13, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Mednax, Inc. (NYSE: ...
NEW YORK , Sept. 12, 2018 /PRNewswire/ -- American Express Company (AXP) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the FBI probing pricing practices ...
MEDNAX, Inc. (MD), the nation’s largest provider of newborn hearing screen services, has launched the MEDNAX Audiology Institute, which will promote innovation and collaboration across all aspects of pediatric hearing loss – early detection, diagnosis and treatment – as well as quality and access to care. With more than 25 years of success providing newborn hearing screens, and built upon a well-established infrastructure that supports research, education, quality and safety initiatives, MEDNAX is uniquely positioned to explore opportunities to improve each phase of care for children with hearing loss. Pediatrix Medical Group, Inc., a MEDNAX subsidiary, is the nation’s largest provider of maternal-fetal, newborn and pediatric subspecialty services.
SAN DIEGO, CA / ACCESSWIRE / September 11, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of MEDNAX, Inc. (NYSE: MD). Investors, who purchased ...
NEW YORK, Sept. 09, 2018-- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving ...
RADNOR, PA / ACCESSWIRE / September 8, 2018 / Kaskela Law LLC announces that a class action lawsuit has been filed against Mednax, Inc. (NYSE: MD) ("Mednax" or the "Company") on behalf ...
LOS ANGELES, CA / ACCESSWIRE / September 7, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mednax, Inc. ("Mednax" or the "Company") (NYSE: MD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between February 4, 2016 and July 27, 2017, inclusive (the ''Class Period''), are encouraged to contact the firm before September 10, 2018.
NEW YORK, NY / ACCESSWIRE / September 7, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Mednax, Inc. (NYSE: MD) from February ...
NEW YORK, NY / ACCESSWIRE / September 7, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (NYSE: MD). Such investors are ...
NEW YORK, Sept. 07, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...